Assessment and Care
A new technology has been created to enhance behavioral health care and allow providers to better serve patients. BCNI, an innovative software program, aims to provide the clinician a rapid in-office procedure that produces a quantitative view of their patient’s neurocognitive status that is valid, reliable, objective, and reimbursable. Just as you carefully monitor the vital signs (weight. blood pressure, cholesterol, etc.) of your loved ones, consider the value of having a baseline for neurocognitive functions for those same patients.
BCNI power the tests and the neurocognitive testing has been in use by clinicians and researchers around the world. All patients, age 50 and older, are recommended to have a baseline neurocognitive test performed.

This type of testing has been utilized at respected institutions such as John Hopkins, Duke, UNC, Chapel Hill, the VA and clinical research sites in over 30 countries.
The BCNI assessment process itself is simple. A patient’s test s completed in approximately 30 minutes and is covered by most insurance as well as Medicare. The patient responds to stimuli on the screen by tapping a few keys on the keyboard. The assessment then utilizes scientifically validated objective tests to evaluate the neurocognitive status of the patient and covers a range of mental processes such as motor performance, attention, memory, reaction time and executive function. Following the assessment, a report and interpretation of the patient’s test results will be forwarded.
Medical professionals and researchers know that good health has many dimensions, one of the most important and yet least measured is the health of a patient’s brain. Now with the advent of BCNI clinicians have an east-to-use clinical tool that ineasures neurocognitive functions, such as Memory, Reaction Time,Psychomotor Speed, Complex Attention, and Cognitive Flexibility. Proper neurocognitive function is a major factor in determining a person’s quality of life.

The brain and central nervous system (CNS) have “vital signs,” but they have never been easy to objectively measure. Until now…
BCNI is effective in detecting early signs of dementia, Alzheimer’s, and tracking recovery from neurological problems. This computerized testing platform has been used:
• When lengthier assessments are either impractical or inappropriate
• Measured repeatedly or in patients in whom the diagnosis is known (e.g. mild and severe head injury or early neurodegenerative disease — early dementia and Alzheimer’s)
• To provide a valuable secondary clinical endpoint that may be an indicator for compliance or quality of life (e.g. psychiatric symptoms , chemo fog, fibro fog, sleep disorders, medication effects)
• In lengthy clinical treatment programs where minimal disruptions for cognitive assessment may be beneficial (e.g. cardiac surgery)
When the monitoring and management of medications is necessary (e.g. Alzheimer’s, depression, behavioral problems).

The psychometric characteristics of the tests are very similar to the characteristics of the conventional neuropsychological tests upon which they are based.
To learn more about BCNI call Senior PsychCare at 713-850-0049